Fundraising Fox
Cellibre
San Diego, US · Founded 2017 · Delaware corporation · 10 known investors
Find your way into Cellibre
Sign up to see every warm intro you have to Cellibre
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cellibre team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cellibre engineers biological manufacturing by programming cells to produce industrial products through fermentation rather than traditional chemical synthesis. The company serves manufacturers seeking sustainable, cost-effective production of chemicals, materials, and other goods using cellular factories.
Founders & leadership
Cellibre was founded in 2017 by Ben Chiarelli.
Investors · 10
How we know: av.vc · Not right? Tell us
How we know: Dellin Investments's portfolio page · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 2
Reported raises · per SEC filings
Form D private placements$20.8M disclosed across 3 rounds · 2019–2024
▶$6.7MraisedOct 2024 · 31 investors · BiotechnologyRule 506(b)
- Nicky CaiazzaExecutive Officer, Director
- Scott ZingheimExecutive Officer, Director
- Spiros KambourakisExecutive Officer, Director
- Benjamin ChiarelliExecutive Officer, Director
- Offering amount
- $23.2M
- Amount sold
- $6.7M
- Minimum investment
- $521
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.9MraisedSep 2021 · 35 investors · BiotechnologyRule 506(b)
- Benjamin ChiarelliExecutive Officer, Director
- Scott ZingheimExecutive Officer, Director
- Nicky CaiazzaExecutive Officer, Director
- Spiros KambourakisExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $9.9M
- Minimum investment
- $5K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4.2MraisedJul 2019 · 21 investors · BiotechnologyRule 506(b)
- Benjamin ChiarelliExecutive Officer
- Offering amount
- $5M
- Amount sold
- $4.2M
- Sales commissions
- $72K
- Placement agents
- Paradigm Capital U.S., Inc.
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Cellibre.
In the news
Frequently asked questions
- What does Cellibre do?
- Cellibre engineers biological manufacturing by programming cells to produce industrial products through fermentation rather than traditional chemical synthesis. The company serves manufacturers seeking sustainable, cost-effective production of chemicals, materials, and other goods using cellular factories.
- Who founded Cellibre?
- Cellibre was founded by Ben Chiarelli in 2017.
- Who are Cellibre's investors?
- Cellibre's investors include Alumni Ventures, Beresford Ventures, Dellin Investments, Delta Emerald Ventures, JourneyOne Ventures, Merida Capital Holdings, Flatiron Venture Partners, New Form Capital.
- How much funding has Cellibre raised?
- Cellibre has disclosed $20.8M raised across 3 rounds.
- Where is Cellibre headquartered?
- Cellibre is headquartered in San Diego, US.